Edwards Justin P, Hand Timothy W, Morais da Fonseca Denise, Glass Deborah D, Belkaid Yasmine, Shevach Ethan M
Cellular Immunology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Eur J Immunol. 2016 Jun;46(6):1480-9. doi: 10.1002/eji.201546204. Epub 2016 Apr 23.
Treg cells can secrete latent TGF-β1 (LTGF-β1), but can also utilize an alternative pathway for transport and expression of LTGF-β1 on the cell surface in which LTGF-β1 is coupled to a distinct LTGF-β binding protein termed glycoprotein A repetitions predominant (GARP)/LRRC32. The function of the GARP/LTGF-β1 complex has remained elusive. Here, we examine in vivo the roles of GARP and TGF-β1 in the induction of oral tolerance. When Foxp3(-) OT-II T cells were transferred to wild-type recipient mice followed by OVA feeding, the conversion of Foxp3(-) to Foxp3(+) OT-II cells was dependent on recipient Treg cells. Neutralization of IL-2 in the recipient mice also abrogated this conversion. The GARP/LTGF-β1 complex on recipient Treg cells, but not dendritic cell-derived TGF-β1, was required for efficient induction of Foxp3(+) T cells and for the suppression of delayed hypersensitivity. Expression of the integrin αvβ8 by Treg cells (or T cells) in the recipients was dispensable for induction of Foxp3 expression. Transient depletion of the bacterial flora enhanced the development of oral tolerance by expanding Treg cells with enhanced expression of the GARP/LTGF-β1 complex.
调节性T细胞(Treg细胞)可分泌潜伏性转化生长因子β1(LTGF-β1),但也可利用另一条途径将LTGF-β1转运并表达于细胞表面,在此途径中,LTGF-β1与一种名为富含糖蛋白A重复序列(GARP)/富含亮氨酸重复序列蛋白32(LRRC32)的独特LTGF-β结合蛋白结合。GARP/LTGF-β1复合物的功能一直尚不明确。在此,我们在体内研究了GARP和转化生长因子β1(TGF-β1)在诱导口服耐受中的作用。当将Foxp3(-)OT-II T细胞转移至野生型受体小鼠,随后喂食卵清蛋白(OVA)时,Foxp3(-)OT-II细胞向Foxp3(+)OT-II细胞的转化依赖于受体Treg细胞。中和受体小鼠中的白细胞介素-2(IL-2)也可消除这种转化。受体Treg细胞上的GARP/LTGF-β1复合物,而非树突状细胞来源的TGF-β1,是有效诱导Foxp3(+)T细胞和抑制迟发型超敏反应所必需的。受体中Treg细胞(或T细胞)整合素αvβ8的表达对于诱导Foxp3表达并非必需。短暂清除细菌菌群可通过扩增表达增强的GARP/LTGF-β1复合物的Treg细胞来增强口服耐受的形成。